title: Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells.
abstract: The generation of efficacious vaccines against self-antigens expressed in tumor cells requires breakage of tolerance, and the refocusing of immune responses toward epitopes for which tolerance may not be established. While the presentation of tumor antigens by mature dendritic cells (mDC) may surpass tolerance, broadening of the antigenic repertoire remains an issue. We report that fusion of the candidate idiotype vaccine IGKV3-20 to the Gly-Ala repeat (GAr) of the Epstein-Barr virus nuclear antigen (EBNA)-1 inhibits degradation by the proteasome and redirects processing to the lysosome. mDCs transduced with a recombinant lentivirus encoding the chimeric idiotype efficiently primed CD4+ and CD8+ cytotoxic T-cell (CTL) responses that lysed autologous blasts expressing IGKV3-20 or pulsed with IGKV3-20 synthetic peptides, and HLA-matched IGKV3-20-positive tumor cell lines. Comparison of the cytotoxic response of CD4+ and CD8+ T lymphocytes activated by mDCs expressing the wild-type or chimeric IGKV3-20 reveled largely non-overlapping epitope repertoires in both CD4+ and CD8+ effectors. Thus, fusion to the GAr may provide an effective means to broaden the immune response to an endogenous protein by promoting the presentation of antigenic epitopes that require a lysosome-dependent processing step.
authors.affiliation: Cancer Bio-immunotherapy Unit, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy.
authors.forename: Debora
authors.initials: D
authors.lastname: Martorelli
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Coppotelli
authors.forename: Elena
authors.initials: E
authors.lastname: Muraro
authors.forename: Riccardo
authors.initials: R
authors.lastname: Dolcetti
authors.forename: Maria G
authors.initials: MG
authors.lastname: Masucci
mesh_terms: D019496:Cancer Vaccines / Q000276:immunology*; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000166:cytology* / Q000276:immunology; D000939:Epitopes / Q000276:immunology*; D057809:HEK293 Cells; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D016086:Lentivirus / Q000235:genetics; D008247:Lysosomes / Q000378:metabolism*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D019496:Cancer Vaccines; D000939:Epitopes; D007130:Immunoglobulin Idiotypes
references.citation: J Immunol. 2002 Jul 1;169(1):350-8
references.pmid: 12077264
references.citation: Nature. 1999 Oct 14;401(6754):708-12
references.pmid: 10537110
references.citation: Crit Rev Oncol Hematol. 2008 Mar;65(3):191-9
references.pmid: 18055210
references.citation: Oncogene. 1998 Mar;16(11):1429-41
references.pmid: 9525742
references.citation: J Biol Chem. 2011 Jun 3;286(22):19565-75
references.pmid: 21471195
references.citation: Cancer. 1988 Feb 1;61(3):483-90
references.pmid: 3338018
references.citation: Nat Immunol. 2009 May;10(5):480-7
references.pmid: 19305394
references.citation: Blood. 2005 Nov 15;106(10):3575-83
references.pmid: 16076869
references.citation: J Transl Med. 2010 Feb 19;8:18
references.pmid: 20170491
references.citation: J Leukoc Biol. 1995 Apr;57(4):543-7
references.pmid: 7722412
references.citation: Future Oncol. 2011 Jan;7(1):111-22
references.pmid: 21174542
references.citation: Tissue Antigens. 2008 Nov;72(5):491-2
references.pmid: 18764807
references.citation: J Clin Oncol. 2011 Jul 10;29(20):2787-94
references.pmid: 21632504
references.citation: Cell Mol Life Sci. 2011 May;68(9):1533-41
references.pmid: 21390546
references.citation: Science. 2005 Mar 11;307(5715):1630-4
references.pmid: 15761154
references.citation: Blood. 2000 Nov 15;96(10):3578-84
references.pmid: 11071657
references.citation: J Exp Med. 2006 Sep 4;203(9):2049-55
references.pmid: 16908625
references.citation: Immunity. 2010 Oct 29;33(4):464-78
references.pmid: 21029958
references.citation: J Immunother. 2008 Nov-Dec;31(9):793-805
references.pmid: 18833008
references.citation: Blood. 2010 Jan 21;115(3):581-91
references.pmid: 19965661
references.citation: J Immunol Methods. 1999 Jun 24;226(1-2):29-41
references.pmid: 10410969
references.citation: Cancer Immunol Immunother. 2009 Jun;58(6):887-900
references.pmid: 18998129
references.citation: J Exp Med. 2004 Feb 16;199(4):459-70
references.pmid: 14769850
references.citation: Br J Haematol. 2007 Nov;139(3):415-24
references.pmid: 17910631
references.citation: J Leukoc Biol. 2006 Aug;80(2):278-86
references.pmid: 16769767
references.citation: PLoS One. 2010 Jun 30;5(6):e11400
references.pmid: 20628596
references.citation: Blood Cells Mol Dis. 2008 Sep-Oct;41(2):215-8
references.pmid: 18640859
references.citation: Hum Gene Ther. 2008 Jun;19(6):622-34
references.pmid: 18533892
references.citation: J Transl Med. 2009 Dec 18;7:109
references.pmid: 20021667
references.citation: Science. 2005 Jan 28;307(5709):593-6
references.pmid: 15591165
references.citation: Blood. 2004 Nov 1;104(9):2879-85
references.pmid: 15217826
references.citation: Br J Haematol. 2003 May;121(3):428-38
references.pmid: 12716365
references.citation: Blood. 1998 Apr 1;91(7):2433-42
references.pmid: 9516143
references.citation: Ann N Y Acad Sci. 2009 Sep;1173:152-60
references.pmid: 19758144
references.citation: J Biol Chem. 2004 Mar 5;279(10):8635-41
references.pmid: 14688254
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8381-5
references.pmid: 10890896
references.citation: Leuk Lymphoma. 2009 Jan;50(1):37-46
references.pmid: 19125383
references.citation: Curr Gene Ther. 2008 Dec;8(6):438-48
references.pmid: 19075627
references.citation: Drugs Today (Barc). 2008 Apr;44(4):271-8
references.pmid: 18536785
references.citation: Tissue Antigens. 2010 Feb;75(2):127-35
references.pmid: 20002609
references.citation: Br J Rheumatol. 1989 Oct;28(5):458-9
references.pmid: 2790414
references.citation: Eur J Immunol. 2002 Mar;32(3):903-10
references.pmid: 11870635
references.citation: Nature. 1995 Jun 22;375(6533):685-8
references.pmid: 7540727
references.citation: Int J Cancer. 1976 Oct 15;18(4):421-31
references.pmid: 789258
references.citation: Tissue Antigens. 2008 Sep;72(3):187-94
references.pmid: 18627571
references.citation: Nat Med. 1998 Aug;4(8):939-44
references.pmid: 9701247
references.citation: RNA. 2003 Apr;9(4):493-501
references.pmid: 12649500
references.citation: J Virol. 2009 Feb;83(3):1289-98
references.pmid: 19019958
references.citation: Immunol Rev. 2008 Jun;223:391-421
references.pmid: 18613849
references.citation: Mol Biotechnol. 2011 Mar;47(3):262-9
references.pmid: 20938757
references.citation: Am J Transplant. 2003 Nov;3(11):1369-77
references.pmid: 14525597
references.citation: Am J Hum Genet. 1985 Sep;37(5):873-82
references.pmid: 3840328